Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of -48157.14% is 3164% below its 5-year average of -1475.61%, near the high end of its 5-year range (-385700.00%–0.00%).
71.85% above its 12-month average of -171100.00%.
Reported quarterly EBITDA margin; no daily interpolation. Q3 FY2025 (2025-09-30): -342200.00%.
EBITDA MARGIN
-48157.14%
EBITDA MARGIN AVG TTM
-171100.00%
EBITDA MARGIN AVG 3Y
-58482.84%
EBITDA MARGIN AVG 5Y
-1475.61%
EBITDA MARGIN AVG 10Y
-1367.27%
EBITDA MARGIN AVG 15Y
-1564.87%
EBITDA MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+71.85%
CURRENT VS 3Y AVG
+17.66%
CURRENT VS 5Y AVG
-3163.54%
CURRENT VS 10Y AVG
-3422.14%
CURRENT VS 15Y AVG
-2977.39%
CURRENT VS 20Y AVG
N/A
Talphera, Inc.
Market Cap
$57.61M
EBITDA Margin
-48157.14%
TTM Avg
-171100.00%
3Y Avg
-58482.84%
5Y Avg
-1475.61%
Market Cap
$58.06M
EBITDA Margin
-16170.91%
TTM Avg
-8243.87%
3Y Avg
-8243.87%
5Y Avg
-8243.87%
Market Cap
$57.01M
EBITDA Margin
-89640.62%
TTM Avg
-44862.17%
3Y Avg
-44862.17%
5Y Avg
-44862.17%
Market Cap
$58.29M
EBITDA Margin
-3226.05%
TTM Avg
-3226.05%
3Y Avg
-3226.05%
5Y Avg
-3226.05%
Market Cap
$58.43M
EBITDA Margin
-270.28%
TTM Avg
-442.93%
3Y Avg
-1031.00%
5Y Avg
-861.19%
Market Cap
$58.44M
EBITDA Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$59.18M
EBITDA Margin
-92.40%
TTM Avg
-510.72%
3Y Avg
-510.72%
5Y Avg
-510.72%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Talphera, Inc. (TLPH) | $57.61M | -48157.14% | -171100.00% | -58482.84% | -1475.61% |
| Boundless Bio, Inc. (BOLD)vs › | $57.76M | N/A | N/A | N/A | N/A |
| Kalaris Therapeutics Inc (KLRS)vs › | $58.06M | -16170.91% | -8243.87% | -8243.87% | -8243.87% |
| Connect Biopharma Holdings Limited (CNTB)vs › | $57.01M | -89640.62% | -44862.17% | -44862.17% | -44862.17% |
| MiNK Therapeutics, Inc. (INKT)vs › | $58.29M | -3226.05% | -3226.05% | -3226.05% | -3226.05% |
| Adicet Bio, Inc. (ACET)vs › | $58.43M | -270.28% | -442.93% | -1031.00% | -861.19% |
| PDS Biotechnology Corporation (PDSB)vs › | $58.44M | N/A | N/A | N/A | N/A |
| Xilio Therapeutics, Inc. (XLO)vs › | $59.18M | -92.40% | -510.72% | -510.72% | -510.72% |
| OKYO Pharma Limited (OKYO)vs › | $56.02M | N/A | N/A | N/A | N/A |
| Aldeyra The (ALDX)vs › | $55.25M | N/A | N/A | N/A | N/A |
Gross Margin
100.0%
EBITDA Margin
-48157.1%
Operating Margin
-48157.1%
Net Margin
-1507600.0%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2025-09-30 | -342200.00% |
| 2025-03-31 | 0.00% |
| 2023-12-31 | -1524.20% |
| 2023-09-30 | -2828.21% |
| 2023-06-30 | -1549.41% |
| 2022-12-31 | -2795.24% |
| 2022-06-30 | -1440.53% |
| 2021-12-31 | -385700.00% |
| 2021-09-30 | -437.70% |
| 2021-06-30 | -2130.02% |
| 2021-03-31 | -1700.98% |
| 2020-12-31 | -1200.81% |
| 2020-09-30 | -624.63% |
| 2020-06-30 | -216.89% |
| 2020-03-31 | -3979.53% |
| 2019-12-31 | -3047.79% |
| 2019-09-30 | -2157.07% |
| 2019-06-30 | -1376.73% |
| 2019-03-31 | -4524.53% |
| 2018-12-31 | -1767.86% |
| 2018-09-30 | -2436.60% |
| 2018-06-30 | -856.85% |
| 2018-03-31 | -2367.35% |
| 2017-12-31 | -1006.89% |
| 2017-09-30 | -566.31% |
| 2017-06-30 | -356.26% |
| 2017-03-31 | -372.89% |
| 2016-12-31 | -103.05% |
| 2016-09-30 | -221.60% |
| 2016-06-30 | -172.26% |
| 2016-03-31 | -264.79% |
| 2015-12-31 | -407.75% |
| 2015-09-30 | 49.33% |
| 2015-06-30 | -395.63% |
| 2015-03-31 | -5612.15% |
| 2014-12-31 | -5036.28% |
| 2014-09-30 | -101.93% |
| 2014-06-30 | -17047.89% |
| 2014-03-31 | -8820.00% |
| 2013-12-31 | 72.94% |
| 2013-09-30 | -1488.87% |
| 2013-06-30 | -1873.22% |
| 2013-03-31 | -1109.36% |
| 2012-12-31 | -471.10% |
| 2012-09-30 | -4856.02% |
| 2012-06-30 | -3024.11% |
| 2012-03-31 | -1939.82% |
| 2011-12-31 | -901.76% |
| 2011-09-30 | -1296.32% |
| 2011-06-30 | -11260.00% |
